Biogen (BIIB) free cash flow

Free cash flow · fiscal 2025
$1.97B

Biogen (BIIB) generated free cash flow of $1.97B in fiscal 2025 (the year ended December 31, 2025). That is 21.7% lower than the $2.52B of fiscal 2024. Figures as of 18 Nov 2026, 12:02 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Free cash flow, fiscal 2025
$1.97B
Change on fiscal 2024
−21.7%
Growth, 5 years
−12.3% a year
Growth, 10 years
−5.0% a year
Highest on record
$6.56Bfiscal 2019
Lowest on record
$734.65Mfiscal 2007
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Biogen free cash flow, in more detail

Over the five fiscal years to 2025 free cash flow shrank at a compound 12.3% a year; over ten years the rate was −5.0% a year. Across the 19 fiscal years on record (2007–2025), the highest was $6.56B in fiscal 2019 and the lowest $734.65M in fiscal 2007.

History · 19 fiscal years

Free cash flow by fiscal year

Biogen free cash flow, year by year

Biogen (BIIB) free cash flow by fiscal year
Fiscal yearFree cash flowChangeYear ended
2025$1.97B 21.7% down
2024$2.52B 103.6% up
2023$1.24B 8.3% up
2022$1.14B 66.3% down
2021$3.38B 11.1% down
2020$3.81B 42.0% down
2019$6.56B 21.2% up
2018$5.42B 47.1% up
2017$3.68B 7.2% down
2016$3.97B 21.2% up
2015$3.28B 23.4% up
2014$2.65B 26.5% up
2013$2.10B 29.1% up
2012$1.63B 7.0% up
2011$1.52B 4.7% up
2010$1.45B 59.6% up
2009$909.25M 29.3% down
2008$1.29B 75.1% up
2007$734.65M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement.

How to read it

It is the cash left for dividends, buybacks, debt repayment and acquisitions; profit that never turns into free cash flow deserves a second look.

Free cash flow at health care companies of similar size

Free cash flow of Biogen and comparable companies
CompanyFree cash flowFiscal year
Biogen BIIB$1.97B2025
Mettler-Toledo International MTD$848.65M2025
Centene CNC$4.32B2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIIB

Biogen, figure by figure

Biogen (BIIB) overview: price, valuation and scorecardAll health care companies by market value

Biogen free cash flow: questions and answers

What is Biogen's free cash flow?

Biogen (BIIB) generated free cash flow of $1.97B in fiscal 2025 (the year ended December 31, 2025). That is 21.7% lower than the $2.52B of fiscal 2024.

What is the growth rate of Biogen's free cash flow?

Over the five fiscal years to 2025 free cash flow shrank at a compound 12.3% a year; over ten years the rate was −5.0% a year.

What are the highest and lowest free cash flow figures on record for Biogen?

Across the 19 fiscal years on record (2007–2025), the highest was $6.56B in fiscal 2019 and the lowest $734.65M in fiscal 2007.

How is Biogen's free cash flow calculated?

Free cash flow is the cash generated by operations minus capital spending, both taken from the cash-flow statement. For Biogen it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Biogen (BIIB) free cash flow”, data as of 18 November 2026. https://funkfolio.com/stock/BIIB/free-cash-flow

Underlying data: the company's filings with the SEC and Yahoo Finance.